A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids

BACKGROUND: Patients with asthma uncontrolled on inhaled corticosteroids may benefit from umeclidinium (UMEC), a long-acting muscarinic antagonist. METHODS: This Phase IIb, double-blind study included patients with reversible, uncontrolled/partially-controlled asthma for ≥6 months, receiving ≥100 mc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Respir Res
Main Authors: Kerwin, Edward, Pascoe, Steven, Bailes, Zelie, Nathan, Robert, Bernstein, David, Dahl, Ronald, von Maltzahn, Robyn, Robbins, Kevin, Fowler, Andrew, Lee, Laurie
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2020
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7291639/
https://ncbi.nlm.nih.gov/pubmed/32532275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01400-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker